365270 — Curacle Co Balance Sheet
0.000.00%
- KR₩118bn
- KR₩103bn
- KR₩2bn
Annual balance sheet for Curacle Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2018 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9,656 | 45,442 | 31,584 | 40,841 | 30,346 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 183 | 1,322 | 3,420 | 1,825 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,083 | 46,522 | 33,407 | 44,473 | 32,417 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 120 | 18,291 | 21,172 | 20,826 | 23,079 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 10,564 | 65,529 | 55,657 | 69,782 | 59,288 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 109 | 2,384 | 1,371 | 10,197 | 20,986 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 12,246 | 10,513 | 9,487 | 27,919 | 29,335 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | -1,681 | 55,017 | 46,171 | 41,863 | 29,953 |
| Total Liabilities & Shareholders' Equity | 10,564 | 65,529 | 55,657 | 69,782 | 59,288 |
| Total Common Shares Outstanding |